百花医药龙虎榜数据（9月4日）

Core Points - Baihua Pharmaceutical (600721) experienced a stock price increase of 6.24% with a turnover rate of 35.69% and a trading volume of 1.463 billion yuan, indicating significant market activity [2] - The stock was listed on the Shanghai Stock Exchange due to its high turnover rate, with a net selling amount of 57.5752 million yuan from brokerage seats [2] - The top five brokerage seats accounted for a total transaction amount of 302 million yuan, with a buying amount of 122 million yuan and a selling amount of 180 million yuan, resulting in a net selling of 57.5752 million yuan [2] Trading Data - The largest buying brokerage was Guotai Junan Securities Co., Ltd. Shanghai Changning District Jiangsu Road Securities Office, with a buying amount of 36.5685 million yuan [2] - The largest selling brokerage was Kaiyuan Securities Co., Ltd. Xi'an West Street Securities Office, with a selling amount of 60.8128 million yuan [2] - The stock saw a net inflow of 54.0097 million yuan from main funds, with a significant inflow of 62.8722 million yuan from large orders, while large orders saw a net outflow of 8.8626 million yuan [2] Financial Performance - For the first half of the year, Baihua Pharmaceutical reported a total revenue of 202 million yuan, representing a year-on-year growth of 2.95% [2] - The net profit for the same period was 25.4834 million yuan, showing a year-on-year increase of 12.45% [2]